Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Lanford, B. Guerra, Helen Lee, D. Averett, Brad Pfeiffer, D. Chavez, L. Notvall, Catherine Bigger (2003)
Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic RepliconsJournal of Virology, 77
Liang-Guo Xu, Y. Wang, Ke-jun Han, Lianyun Li, Z. Zhai, H. Shu (2005)
VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 19
M. Ikeda, K. Abe, H. Dansako, Takashi Nakamura, K. Naka, N. Kato (2005)
Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.Biochemical and biophysical research communications, 329 4
Zhengfan Jiang, T. Mak, G. Sen, Xiaoxia Li (2004)
Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-βProceedings of the National Academy of Sciences of the United States of America, 101
Kui Li, Eileen Foy, J. Ferreon, Mitsuyasu Nakamura, A. Ferreon, M. Ikeda, S. Ray, M. Gale, S. Lemon (2005)
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.Proceedings of the National Academy of Sciences of the United States of America, 102 8
H. Kishine, K. Sugiyama, M. Hijikata, N. Kato, Hitoshi Takahashi, Takeshi Noshi, Y. Nio, M. Hosaka, Yusuke Miyanari, K. Shimotohno (2002)
Subgenomic replicon derived from a cell line infected with the hepatitis C virus.Biochemical and biophysical research communications, 293 3
L. Alexopoulou, Agnieszka Holt, R. Medzhitov, R. Flavell (2001)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3Nature, 413
G. Kuo, Q. Choo, H. Alter, G. Gitnick, A. Redeker, R. Purcell, T. Miyamura, J. Dienstag, M. Alter, C. Stevens (1989)
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitisScience, 244
H. Dansako, K. Naka, M. Ikeda, N. Kato (2005)
Hepatitis C virus proteins exhibit conflicting effects on the interferon system in human hepatocyte cells.Biochemical and biophysical research communications, 336 2
P. Benech, M. Vigneron, D. Peretz, M. Revel, J. Chebath (1987)
Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase geneMolecular and Cellular Biology, 7
K. Naka, H. Dansako, N. Kobayashi, M. Ikeda, N. Kato (2006)
Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes.Virology, 346 2
S. Alam, Takashi Nakamura, A. Naganuma, A. Nozaki, K. Nouso, H. Shimomura, N. Kato (2002)
Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region.Acta medica Okayama, 56 3
S. Ohkoshi, H. Kojima, H. Tawaraya, T. Miyajima, T. Kamimura, H. Asakura, A. Satoh, S. Hirose, M. Hijikata, N. Kato (1990)
Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma.Japanese journal of cancer research : Gann, 81 6-7
T. Wakita, T. Pietschmann, Takanobu Kato, Takanobu Kato, T. Date, M. Miyamoto, Zijiang Zhao, K. Murthy, A. Habermann, H. Kräusslich, M. Mizokami, R. Bartenschlager, T. Liang (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 11
I. Saito, T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Yushiro Watanabe, S. Koi, M. Onji, Y. Ohta (1990)
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 87 17
Shintaro Sato, Masanaka Sugiyama, Masahiro Yamamoto, Yasuyuki Watanabe, T. Kawai, K. Takeda, S. Akira (2003)
Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1The Journal of Immunology, 171
R. Sumpter, Y. Loo, Eileen Foy, Kui Li, M. Yoneyama, T. Fujita, S. Lemon, M. Gale (2005)
Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-IJournal of Virology, 79
T. Akagi, Ken Sasai, H. Hanafusa (2003)
Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformationProceedings of the National Academy of Sciences of the United States of America, 100
N. Kato (2001)
Molecular virology of hepatitis C virus.Acta medica Okayama, 55 3
Y. Komoda, M. Hijikata, S. Sato, Shin Asabe, K. Kimura, K. Shimotohno (1994)
Substrate requirements of hepatitis C virus serine proteinase for intermolecular polypeptide cleavage in Escherichia coliJournal of Virology, 68
J. Ferreon, A. Ferreon, Kui Li, S. Lemon (2005)
Molecular Determinants of TRIF Proteolysis Mediated by the Hepatitis C Virus NS3/4A Protease*Journal of Biological Chemistry, 280
Kui Li, Zihong Chen, N. Kato, M. Gale, S. Lemon (2005)
Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in Hepatocytes*Journal of Biological Chemistry, 280
N. Kato, H. Sekiya, Y. Ootsuyama, T. Nakazawa, M. Hijikata, S. Ohkoshi, K. Shimotohno (1993)
Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virusJournal of Virology, 67
H. Dansako, M. Ikeda, K. Abe, Kyoko Mori, K. Takemoto, Y. Ariumi, N. Kato (2008)
A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.Virus research, 137 1
M. Ueta, J. Hamuro, H. Kiyono, S. Kinoshita (2005)
Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines.Biochemical and biophysical research communications, 331 1
Misao Kuroki, Y. Ariumi, M. Ikeda, H. Dansako, T. Wakita, N. Kato (2008)
Arsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative StressJournal of Virology, 83
M. Ikeda, N. Kato, T. Mizutani, K. Sugiyama, Katsuaki Tanaka, K. Shimotohno (1997)
Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes.Journal of hepatology, 27 3
Makoto HuIKATA, Hiroto MIZUSHIMAt, Y. Tanji, Y. Komoda, Y. Hirowatari, T. Akagi, N. Kato, KoICHI KIMURAt, K. Shimotohno (1993)
Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus.Proceedings of the National Academy of Sciences of the United States of America, 90 22
E. Meylan, J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, J. Tschopp (2005)
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 437
M. Yoneyama, M. Kikuchi, Kanae Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, Eileen Foy, Y. Loo, M. Gale, S. Akira, S. Yonehara, A. Kato, T. Fujita (2005)
Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1The Journal of Immunology, 175
M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, T. Fujita (2004)
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 5
M. Ikeda, K. Sugiyama, T. Mizutani, T. Tanaka, K. Tanaka, H. Sekihara, K. Shimotohno, N. Kato (1998)
Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus.Virus research, 56 2
Torahiko Tanaka, N. Kato, M. Cho, K. Shimotohno (1995)
A novel sequence found at the 3' terminus of hepatitis C virus genome.Biochemical and biophysical research communications, 215 2
M. Hijikata, N. Kato, Y. Ootsuyama, M. Nakagawa, K. Shimotohno (1991)
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.Proceedings of the National Academy of Sciences of the United States of America, 88
D. Kang, R. Gopalkrishnan, Qingping Wu, E. Jankowsky, A. Pyle, P. Fisher (2002)
mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive propertiesProceedings of the National Academy of Sciences of the United States of America, 99
Xiao-Dong Li, Lijun Sun, Rashu Seth, Gabriel Pineda, Zhijian Chen (2005)
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.Proceedings of the National Academy of Sciences of the United States of America, 102 49
H. Dansako, M. Ikeda, N. Kato (2007)
Limited suppression of the interferon‐β production by hepatitis C virus serine protease in cultured human hepatocytesThe FEBS Journal, 274
N. Kato, M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, Takashi Sugimura, K. Shimotohno (1990)
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.Proceedings of the National Academy of Sciences of the United States of America, 87 24
K. Honda, T. Taniguchi (2006)
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptorsNature Reviews Immunology, 6
David Thomas (2000)
Hepatitis C epidemiology.Current topics in microbiology and immunology, 242
Q. Choo, G. Kuo, A. Weiner, L. Overby, D. Bradley, M. Houghton (1989)
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science, 244 4902
H. Dansako, A. Naganuma, Takashi Nakamura, F. Ikeda, A. Nozaki, N. Kato (2003)
Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.Virus research, 97 1
We previously demonstrated that hepatitis C virus (HCV) serine protease NS3-4A was unable to cleave TRIF (adaptor protein of Toll-like receptor 3), resulting in a lack of suppression of the TRIF-mediated pathway, whereas NS3-4A cleaved Cardif (adaptor protein of retinoic acid-inducible gene I or melanoma differentiation-associated gene-5), resulting in an interruption of the Cardif-mediated pathway in non-neoplastic human hepatocyte PH5CH8 cells. To elucidate these observations, we examined the cleavage potential of NS3-4A for TRIF in PH5CH8 cells, genome-length HCV RNA-replicating O cells, and HCV-infected cells, and we demonstrated that NS3-4A lacked the ability to cleave endogenous TRIF, regardless of HCV strains derived from patients with different stages of hepatic disease. Furthermore, we demonstrated that inflammatory cytokine production by NF-κB activation via the TRIF-mediated pathway also remained unsuppressed by NS3-4A. These results suggest that the inhibitory effects of NS3-4A on antiviral signaling pathways are limited to the Cardif-mediated pathway in human hepatocytes.
Archives of Virology – Springer Journals
Published: May 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.